An Imbalanced GLP-1R/GIPR Co-Agonist Peptide with a Site-Specific N-terminal PEGylation to Maximize Metabolic Benefits
iScience（2024）
关键词
Glucagon-like peptide 1 receptor,Glucose-dependent insulinotropic polypeptide receptor,Imbalanced agonist,Site-specific PEGylation,Diabetes,Obesity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要